Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05719_nanopub.RADTGP9cHT51-15StZQ_R6hknBzGp-ADtbcth-3qaCONg#assertion>. }
Showing items 1 to 13 of
13
with 100 items per page.
- drugbank:DB05719 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05719 label "Elesclomol [drugbank:DB05719]" assertion.
- drugbank:DB05719 seeAlso DB05719 assertion.
- drugbank:DB05719 description "Elesclomol is a novel, injectable, drug candidate that kills cancer cells by elevating oxidative stress levels beyond a breaking point, triggering programmed cell death. In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal additional toxicity, at moderate doses. It is being developed by Synta Pharmaceuticals." assertion.
- drugbank:DB05719 identifier "drugbank:DB05719" assertion.
- drugbank:DB05719 title "Elesclomol" assertion.
- drugbank:DB05719 drugbank_vocabulary:x-chemspider chemspider:265501 assertion.
- drugbank:DB05719 drugbank_vocabulary:x-cas cas:488832-69-5 assertion.
- drugbank:DB05719 drugbank_vocabulary:drugbank-id "DB05719" assertion.
- drugbank:DB05719 bio2rdf_vocabulary:x-identifiers.org DB05719 assertion.
- drugbank:DB05719 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05719" assertion.
- drugbank:DB05719 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05719 bio2rdf_vocabulary:identifier "DB05719" assertion.